Scleroderma drug trial shows up to 60% improvement
Drug Discovery World
NOVEMBER 30, 2023
Biotechnology company Certa Therapeutics has revealed positive Phase II clinical trial data for FT011 in patients with scleroderma. It is important to advance safe and effective treatments through clinical development, given the limited therapeutic options for scleroderma patients.
Let's personalize your content